Walleye Capital’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
Other funds holding NRIX
Walleye Capital's NRIX Position: Q3 2026 in Review
Walleye Capital sold out of Nurix Therapeutics (NRIX) in Q3 2026, closing a stake of 15,568 shares — an estimated $378K sold.
Walleye Capital first reported a position in NRIX in Q3 2021 and held it in 6 quarters. The position peaked at $1.42M in Q4 2025. 186 funds tracked by Wall St. Rank hold NRIX as of Q3 2026.
- Walleye Capital reported no remaining Nurix Therapeutics position as of Q3 2026 after selling out during the quarter.
- Walleye Capital sold 15,568 Nurix Therapeutics shares in Q3 2026, an estimated $378K.
- Walleye Capital first reported a position in Nurix Therapeutics in Q3 2021 and held it in 6 quarters.
- Walleye Capital's Nurix Therapeutics position peaked at $1.42M in Q4 2025.
- 186 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q3 2026.
Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.